- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03859661
A Study to Evaluate the Palatability of a Nutritional Support Biscuit (Fitabisc) (Fitabisc)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The question of preoperative supplementation raises another issue about how this might be provided for patients, especially at home.
The Chief Investigator has formulated a new biscuit 'Fitabisc' that contains the key antioxidants; vitamins C and E, selenium and glutamine. The advantage of a biscuit is that all ingredients of interest are combined within the one item and so this may be easier for patients to 'take' than other types of supplement. A survey involving 17 community pharmacies in England and Northern Ireland found that 60% of patients aged 60 - 89 years had difficulty swallowing tablets and capsules. The consistency of the biscuit is softer than traditional shortbread and crumbs readily which we hope will make it easy to eat.
The aim of this study is to test the palatability of Fitabisc and whether patients undergoing abdominal surgery can eat it in the desired quantities for 10 days before they are admitted to hospital.
In summary, most studies to date have looked perioperative or postoperative supplementation with antioxidants alone. No attempt has been made to do this using a palatable biscuit that would facilitate preoperative oral supplementation. If this study confirms the palatability of the biscuit and there is adherence to eating it then it would be our intention to set up a prospective randomized study in which the potential efficacy of Fitabisc would be evaluated.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
York, United Kingdom, YO31 8HE
- York Teaching Hospital NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients between the ages of 16 and 80 years inclusive.
- Patients who are having colorectal surgery.
- Patients who are able to give voluntary, written informed consent to participate in the study and from whom written consent has been obtained.
Exclusion Criteria:
- Those who cannot or do not provide informed consent
- Patients with a known or suspected allergy to any of the ingredients of Fitabisc e.g. gluten or dairy products
Patients with one of the following co-morbidities:
- Haemochromatosis
- Thalassaemia
- Kidney disease
- Liver disease
- Reye syndrome
- Patients who already take supplements of vitamin C, E, selenium or glutamine.
- Patients with type 1 diabetes, or type 2 diabetes that requires them to have insulin or a hypoglycaemic drug such as Metformin.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence to dose
Time Frame: 10 days
|
Patients to keep a diary of their consumption
|
10 days
|
Palatability of biscuit
Time Frame: 10 days
|
Study will measure palatability on a standard Likert scale after 10 days
|
10 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Progress of patients following surgery
Time Frame: 4-6 weeks post op.
|
Adverse event collection - via patient reported outcomes and review of patient notes following surgery
|
4-6 weeks post op.
|
Collection of events that might be associated with the ingredients of the biscuit.
Time Frame: 4-6 weeks post op.
|
Adverse event collection - via patient reported outcomes and review of patient notes following surgery
|
4-6 weeks post op.
|
Collaborators and Investigators
Investigators
- Principal Investigator: John Macfie, MBChB, MD, York Teaching Hospital NHS Foundation Trust
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SNE2445
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Surgery
-
Medical University of South CarolinaCompletedColorectal Surgery | Hepatobiliary SurgeryUnited States
-
Gulhane School of MedicineUniversity Hospital, Ghent; Szeged University; University Clinical Centre of... and other collaboratorsCompletedColorectal Disorders | Colorectal SurgeryTurkey
-
York Teaching Hospitals NHS Foundation TrustCompletedColorectal Surgery | Major Abdominal SurgeryUnited Kingdom
-
IHU StrasbourgRecruitingColorectal SurgeryFrance
-
Indiana UniversityCompletedColorectal SurgeryUnited States
-
Wake Forest University Health SciencesWithdrawnColorectal Surgery
-
University of Massachusetts, WorcesterCompleted
-
Helsinki University Central HospitalActive, not recruiting
-
Children's Hospital Medical Center, CincinnatiTerminated
-
Bnai Zion Medical CenternovoGICompleted
Clinical Trials on Fitabisc
-
Hull University Teaching Hospitals NHS TrustWithdrawn